Anxiety Disorders and Depression Treatment Global Market Report 2024-2032: Sturdy Medication Pipelines to Support Development, Economic Cost of Mental Illnesses to Drive Demand
30 août 2024 04h15 HE
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Anxiety Disorders and Depression Treatment Global Market Report, Forecast by Product, Indication, Country and Company Analysis 2024-2032" report has...
Panic Disorder Market Towards US$ 12,621.61 Mn By 2030, A Comprehensive Analysis By Reports Insights
29 mai 2023 05h00 HE
|
REPORTSINSIGHTS CONSULTING PVT LTD
New York, May 29, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Reports Insights, the panic disorder market is poised for strong expansion and is expected to reach USD 12,621.61 Million...
Nobilis Therapeutics to Present at CapCon 2020 Venture Conference
30 oct. 2020 09h00 HE
|
Nobilis Therapeutics, Inc.
PORTLAND, Ore., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Nobilis Therapeutics, a late stage biotechnology company that is developing a drug-device combination for treatment of psychiatric disorders will...
Antidepressant Drugs Market to Grow Valuation of $15.98 Billion by 2023
06 août 2020 10h15 HE
|
Allied Market Research
Portland, OR, Aug. 06, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research,the antidepressant drugs market accounted for $13.75 billion in 2016, and is estimated to...
Fluoxetine Market Research Report By Size, Share, Type, Application and Top Players 2018-2026 | Reports And Data
24 juil. 2019 10h01 HE
|
Reports and Data
New York, July 24, 2019 (GLOBE NEWSWIRE) -- This report on the Fluoxetine market is a thorough analysis of the size, share, demand, growth, gross profits, earnings, and revenue of the industry. It...
CORRECTING and REPLACING - PANIC, an Uplifting Coming-of-Age Story Set in New York City, Explores Cross-Currents Running Through What Author Calls “The Great Anxiety”
27 févr. 2019 09h48 HE
|
Boyle Public Affairs
WASHINGTON, Feb. 27, 2019 (GLOBE NEWSWIRE) -- In a press release issued earlier today under the same headline, a person's name appeared incorrectly. The Social Void member should be Chip Cooley, not...
PANIC, an Uplifting Coming-of-Age Story Set in New York City, Explores Cross-Currents Running Through What Author Calls “The Great Anxiety”
27 févr. 2019 09h00 HE
|
Boyle Public Affairs
WASHINGTON, Feb. 27, 2019 (GLOBE NEWSWIRE) -- The new e-novel PANIC is an uplifting tale of a young man navigating the emotional peaks and valleys of panic disorder. Yet according to its Washington,...
Canbiola, Inc. (OTC PINK: CANB) Revenue and Shareholder 2nd Quarter Update
09 juil. 2018 09h00 HE
|
Canbiola, Inc.
HICKSVILLE, NY. , July 09, 2018 (GLOBE NEWSWIRE) -- Canbiola, Inc. (OTC PINK: CANB) Canbiola is pleased to update shareholders on our progress for the first half of 2018. REVENUES: We expect...
Nobilis Therapeutics’ NBTX-001 shows promise in treatment of patients with Panic Disorder
14 juin 2017 13h34 HE
|
Nobilis Therapeutics, Inc.
PORTLAND, Ore., June 14, 2017 (GLOBE NEWSWIRE) -- Nobilis Therapeutics, Inc. announced today that the results of the clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in...
Behavioral Health Pioneer Palo Alto Health Sciences, Inc. Strengthens Executive Team with New Chief Clinical Officer and Vice President of Business Development
15 sept. 2016 11h00 HE
|
Palo Alto Health Sciences, Inc.
DANVILLE, Calif., Sept. 15, 2016 (GLOBE NEWSWIRE) -- Palo Alto Health Sciences (PAHS), maker of the Freespira Breathing System®, is excited to welcome Dr. Robert Cuyler as Chief Clinical Officer...